Similar articles

• A new strategy of drug treatment in NSAID-unresponsive ankylosing spondylitis: combination of pamidronate and methylprednisolone monthly intravenous infusions on the background of a combination of disease modifying drugs sulfasalazine and methotrexate.

  Malaviya AN, Kapoor S, Garg S, Ahmad I, Raja RR. Malaviya AN, et al. J Assoc Physicians India. 2007 Mar;55:193-7. J Assoc Physicians India. 2007. PMID: 17598330 Clinical Trial.
• [Ankylosing spondylitis].

  El Maghraoui A. El Maghraoui A. Presse Med. 2004 Nov 20;33(20):1459-64. doi: 10.1016/s0755-4982(04)98954-3. Presse Med. 2004. PMID: 15611681 Review. French.
• Clinical inquiries. Are DMARDs effective for rheumatologic diseases besides rheumatoid arthritis?

  Goodemote P, Jamieson B, Hoffman R. Goodemote P, et al. J Fam Pract. 2007 Nov;56(11):933-4, 937. J Fam Pract. 2007. PMID: 17976342 No abstract available.
• The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis.

  Kang KY, Lee KY, Kwok SK, Ju JH, Park KS, Hong YS, Kim HY, Park SH. Kang KY, et al. Joint Bone Spine. 2011 Mar;78(2):188-93. doi: 10.1016/j.jbspin.2010.05.010. Joint Bone Spine. 2011. PMID: 20621536
• Ankylosing spondylitis associated with primary aldosteronism in a middle-aged woman.

  Suh YS, Kim HO, Cheon YH, Jo W, Hong J, Lee SI. Suh YS, et al. Korean J Intern Med. 2017 Mar;32(2):374-377. doi: 10.3904/kjim.2015.116. Epub 2016 Feb 3. Korean J Intern Med. 2017. PMID: 26842104 Free PMC article. Review. No abstract available.